How Are We Unique?
We are laser focused on:
- NAFLD and concurrent Metabolic Syndrome
- Improving our member's wellness at the root cause, not just placing a band-aid on it
- Medical Metrics
- Hemoglobin A1C
- LDL Cholesterol
- Medications for GERD, Diabetes, Hypertension and Hyperlipidemia
- Changes in CPAP settings
- Quality of Life
- Digital Monitoring/Machine Learning
- Life Preservation-preventing premature death via disease reversal
Our focus is NOT on aesthetics
FibroScan: a special ultrasound test that determines:
Steatosis (the amount of fat in the liver), shown as "S" score, range 0-3, 3 being severe
Fibrosis (scare tissue), shown as a F score, range 0-4, 4 being severe)
Our member had a score of S3 and F0-1 prior to starting the NovoLiver program; four months later, she had a score of S0 and F0-1 meaning her liver fat had disappeared.
Our member had a score of S3 and F2 prior to starting the NovoLiver program; nine months later, she had a score of S1 and F0-1 meaning her liver fat had decreased and scarring had improved significantly.
Average Weight Loss of a Member in the Program for Three Months or Longer:
As of November 2022
We're also tracking...
In addition to percentage body weight loss, we are tracking app utilization, support group attendance, changes in quality of life scores via a Short Form-12 (SF12), BMI, changes in anthropometric measurements [waist-to-hip, chest, triceps, quadriceps], changes in non-invasive testing parameters [imaging that captures steatosis & fibrosis levels, plus lab-based scoring systems like Hepatic Steatosis Index (HSI) and Fibrosis 4 Score (FIB-4)]. We are also tracking changes in medications for associated chronic conditions and mitigation of symptoms and signs of such conditions.
Proof of Concept Peer Reviewed Publications
- White Paper AGA POWER-Practice Guide on Obesity and Weight Management, Education and Resources (click here to review article)
- Establishing an Effective Weight Loss Program in a Community-Based Gastroenterology Practice: The Huron Gastro Experience (click here to review article)
- Effective Treatment of Nonalcoholic Fatty Liver Disease using a Community-based Weight Management Program (click here to review article)
- Improvement of Non-Alcoholic Fatty Liver Disease through a Comprehensive Weight Loss Program in a Community Gastroenterology Practice (click here to review article)
- Weight Loss Through Lifestyle Modifications Significantly Reduces Features of Nonalcoholic Steatohepatitis (click here to review article)